该产品被引用文献
PubMed=4203458Petricciani J.C., Wallace R.E., McCoy D.W.A comparison of three in vivo assays for cell tumorigenicity.Cancer Res. 34:105-108(1974)PubMed=327080; DOI=10.1093/jnci/59.1.221Fogh J., Fogh J.M., Orfeo T.One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.J. Natl. Cancer Inst. 59:221-226(1977)PubMed=833871; DOI=10.1093/jnci/58.2.209Fogh J., Wright W.C., Loveless J.D.Absence of HeLa cell contamination in 169 cell lines derived from human tumors.J. Natl. Cancer Inst. 58:209-214(1977)PubMed=90012; DOI=10.1007/BF02618407Noguchi P., Wallace R.E., Johnson J., Earley E.M., O'Brien S., Ferrone S., Pellegrino M.A., Milstien J., Needy C., Browne W., Petricciani J.C.Characterization of the WiDr: a human colon carcinoma cell line.In Vitro 15:401-408(1979)CLPUB00271Wallace R.E., Lindh D., Durr F.E.Studies on the development of resistance to mitoxantrone in human colon carcinoma cells in vitro.Proc. Am. Assoc. Cancer Res. 23:767-767(1982)PubMed=3518877; DOI=10.3109/07357908609038260Fogh J.Human tumor lines for cancer research.Cancer Invest. 4:157-184(1986)PubMed=3472642; DOI=10.1016/0165-4608(87)90267-6Chen T.-R., Drabkowski D., Hay R.J., Macy M.L., Peterson W.D. Jr.WiDr is a derivative of another colon adenocarcinoma cell line, HT-29.Cancer Genet. Cytogenet. 27:125-134(1987)PubMed=3335022Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., Shoemaker R.H., Boyd M.R.Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.Cancer Res. 48:589-601(1988)PubMed=1657424; DOI=10.1007/BF00685821Fischel J.-L., Formento P., Berlion M., Berille J., Gioanni J., Bizzari J.-P., Milano G.Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid.Cancer Chemother. Pharmacol. 28:448-454(1991)PubMed=1389533; DOI=10.1016/0959-8049(92)90031-VLahm H., Petral-Malec D., Yilmaz-Ceyhan A., Fischer J.R., Lorenzoni M., Givel J.-C., Odartchenko N.Growth stimulation of a human colorectal carcinoma cell line by interleukin-1 and -6 and antagonistic effects of transforming growth factor beta 1.Eur. J. Cancer 28:1894-1899(1992)PubMed=8464898; DOI=10.1073/pnas.90.7.2842Browning M.J., Krausa P., Rowan A.J., Bicknell D.C., Bodmer J.G., Bodmer W.F.Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines.Proc. Natl. Acad. Sci. U.S.A. 90:2842-2845(1993)PubMed=7874267; DOI=10.1007/BF02349278Ikuta S., Itoh F., Hinoda Y., Toyota M., Makiguchi Y., Imai K., Yachi A.Expression of cytoskeletal-associated protein tyrosine phosphatase PTPH1 mRNA in human hepatocellular carcinoma.J. Gastroenterol. 29:727-732(1994)PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T., Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M., Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.Screening the p53 status of human cell lines using a yeast functional assay.Mol. Carcinog. 19:243-253(1997)PubMed=10674020; DOI=10.1016/S0959-8049(99)00206-3Ku J.-L., Yoon K.-A., Kim D.-Y., Park J.-G.Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines.Eur. J. Cancer 35:1724-1729(1999)PubMed=10956384; DOI=10.1002/1097-0215(20000915)87:6Backus H.H.J., Pinedo H.M., Wouters D., Padron J.M., Molders N., van der Wilt C.L., van Groeningen C.J., Jansen G., Peters G.J.Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates.Int. J. Cancer 87:771-778(2000)PubMed=11414198; DOI=10.1007/s004320000207Lahm H., Andre S., Hoeflich A., Fischer J.R., Sordat B., Kaltner H., Wolf E., Gabius H.J.Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.J. Cancer Res. Clin. Oncol. 127:375-386(2001)PubMed=16854228; DOI=10.1186/1476-4598-5-29Bandres E., Cubedo E., Agirre X., Malumbres R., Zarate R., Ramirez N., Abajo A., Navarro A., Moreno I., Monzo M., Garcia-Foncillas J.Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues.Mol. Cancer 5:29.1-29.10(2006)PubMed=20143388; DOI=10.1002/ijc.25242Capes-Davis A., Theodosopoulos G., Atkin I., Drexler H.G., Kohara A., MacLeod R.A.F., Masters J.R.W., Nakamura Y., Reid Y.A., Reddel R.R., Freshney R.I.Check your cultures! A list of cross-contaminated or misidentified cell lines.Int. J. Cancer 127:1-8(2010)PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.Cancer Res. 70:2158-2164(2010)PubMed=20570890; DOI=10.1158/0008-5472.CAN-10-0192Janakiraman M., Vakiani E., Zeng Z.-S., Pratilas C.A., Taylor B.S., Chitale D., Halilovic E., Wilson M., Huberman K., Ricarte Filho J.C., Persaud Y., Levine D.A., Fagin J.A., Jhanwar S.C., Mariadason J.M., Lash A., Ladanyi M., Saltz L.B., Heguy A., Paty P.B., Solit D.B.Genomic and biological characterization of exon 4 KRAS mutations in human cancer.Cancer Res. 70:5901-5911(2010)PubMed=23932154; DOI=10.1016/j.radonc.2013.06.032Salendo J., Spitzner M., Kramer F., Zhang X., Jo P., Wolff H.A., Kitz J., Kaulfuss S., Beissbarth T., Dobbelstein M., Ghadimi M., Grade M., Gaedcke J.Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g.Radiother. Oncol. 108:451-457(2013)PubMed=24042735; DOI=10.1038/oncsis.2013.35Ahmed D., Eide P.W., Eilertsen I.A., Danielsen S.A., Eknaes M., Hektoen M., Lind G.E., Lothe R.A.Epigenetic and genetic features of 24 colon cancer cell lines.Oncogenesis 2:e71.1-e71.8(2013)PubMed=25485619; DOI=10.1038/nbt.3080Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S., Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.-M.A comprehensive transcriptional portrait of human cancer cell lines.Nat. Biotechnol. 33:306-312(2015)PubMed=25926053; DOI=10.1038/ncomms8002Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G., Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S., Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M., Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.Nat. Commun. 6:7002-7002(2015)PubMed=26537799; DOI=10.1074/mcp.M115.051235Holst S., Deuss A.J.M., van Pelt G.W., van Vliet S.J., Garcia-Vallejo J.J., Koeleman C.A.M., Deelder A.M., Mesker W.E., Tollenaar R.A., Rombouts Y., Wuhrer M.N-glycosylation profiling of colorectal cancer cell lines reveals association of fucosylation with differentiation and caudal type homebox 1 (CDX1)/villin mRNA expression.Mol. Cell. Proteomics 15:124-140(2016)PubMed=28683746; DOI=10.1186/s12943-017-0691-yBerg K.C.G., Eide P.W., Eilertsen I.A., Johannessen B., Bruun J., Danielsen S.A., Bjornslett M., Meza-Zepeda L.A., Eknaes M., Lind G.E., Myklebost O., Skotheim R.I., Sveen A., Lothe R.A.Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.Mol. Cancer 16:116.1-116.16(2017)
